AEQUUS PHARMACEUTICALS INC

AQS TSXV
AQS
AEQUUS PHARMACEUTICALS INC TSXV
 
Perolehan Mendatang
EPS
Kap Pasar
Dividen yang Dihasilkan
P/E
Perolehan Mendatang
EPS
Kap Pasar
Dividen yang Dihasilkan
P/E

AQS financial statements

Laporan keuangan AEQUUS PHARMACEUTICALS INC, termasuk pendapatan, pengeluaran, laba, dan rugi

The total revenue of AQS for the last quarter is 712.04k CAD, and it's 9.29% higher compared to the previous quarter. The net income of Q3 21 is -381.54k CAD.

TTM
Profit bruto / Gross profit
Total pendapatan
Cost of goods sold
Operating expenses (excl. COGS)
Pemasukan operasional
Non-operating income, total
Pretax income
Equity in earnings
Taxes
Non-controlling/minority interest
After tax other income/expense
Net income before discontinued operations
Discontinued operations
Pendapatan netto
Dilution adjustment
Preferred dividends
Diluted net income available to common stockholders
Basic earnings per share (Basic EPS)
Diluted earnings per share (Diluted EPS)
Average basic shares outstanding
Diluted shares outstanding
EBITDA
EBIT
Total pengeluaran operasi